Holen Sie sich die Stockscreener-App
327.03
1.56%
-5.18
Schlusskurs vom Vortag:
$332.21
Offen:
$330.38
24-Stunden-Volumen:
124.18K
Relative Volume:
0.57
Marktkapitalisierung:
$7.16B
Einnahmen:
$2.58B
Nettoeinkommen (Verlust:
$-778.69M
KGV:
-11.97
EPS:
-27.33
Netto-Cashflow:
$223.75M
1W Leistung:
+7.30%
1M Leistung:
-3.74%
6M Leistung:
+46.14%
1J Leistung:
-3.17%
1-Tages-Spanne:
$326.64
$334.00
1-Wochen-Bereich:
$298.35
$334.53
52-Wochen-Spanne:
$211.43
$373.69
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Firmenname
Bio Rad Laboratories Inc
Sektor
Branche
Telefon
(510) 724-7000
Adresse
1000 ALFRED NOBEL DRIVE, HERCULES
Vergleichen Sie BIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
327.03 | 8.96B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
128.54 | 222.66B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.96 | 150.26B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
372.29 | 143.44B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
105.02 | 135.12B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
86.75 | 50.38B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-06-16 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-01-28 | Bestätigt | Citigroup | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2018-10-17 | Eingeleitet | Goldman | Buy |
| 2018-09-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Herabstufung | CL King | Buy → Neutral |
| 2017-07-13 | Eingeleitet | Wells Fargo | Outperform |
| 2017-06-28 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Hold |
| 2016-10-13 | Eingeleitet | CL King | Buy |
| 2015-05-06 | Bestätigt | Jefferies | Buy |
| 2009-12-18 | Eingeleitet | Maxim Group | Buy |
| 2009-11-06 | Eingeleitet | Jefferies & Co | Buy |
| 2009-07-17 | Eingeleitet | Soleil | Buy |
| 2007-09-26 | Eingeleitet | Banc of America Sec | Buy |
| 2007-02-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Laboratory Proficiency Testing Market- By Type LGC Limited - openPR.com
Understanding Momentum Shifts in (BIO) - news.stocktradersdaily.com
US STD Diagnostics Market Forecast and Company Analysis 2025-2033 Featuring Abbott, F. Hoffmann-La Roche, Hologic, BD and Co, Danaher, Siemens, bioMerieux, Thermo Fisher Scientific, Qiagen, Bio-Rad - GlobeNewswire
Chromatography Accessories and Consumables Market Size, - openPR.com
Gene Transfer Technologies Market is expected to reach US$ 8.74 - openPR.com
Rare Cell Isolation Market See Incredible Growth 2025-2032 with - openPR.com
Peripheral Blood Mononuclear Cells Market Is Booming Worldwide - openPR.com
Enzyme Immunoassay Market Is Booming Worldwide 2025-2032 | Bio-Rad, Roche, Siemens Healthineers, and Abbott - openPR.com
Hemoglobinopathies Market- By Type Abbott Diagnostics, Bio-Rad Laboratories Inc., Danaher Corporation - openPR.com
Hematology Market- By Type Abbott, Agilent, Bio-Rad, Danaher Dolomite - openPR.com
Functional Genomics Market Set to Boom: Strategic Insights - openPR.com
Lab on Chip Market 2025- 2032 Overview: Share, Size, Value, - openPR.com
Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD oncology kits in Europe - MSN
EBITDA per share of Bio-Rad Laboratories, Inc. Class B – FWB:BUW - TradingView
Free cash flow per share of Bio-Rad Laboratories, Inc. Class B – FWB:BUW - TradingView
What analysts say about Bio Rad Laboratories Inc stockPrice Action Trading & Free Tap Rapid Wealth - earlytimes.in
How Bio Rad Laboratories Inc. (BUW) stock correlates with oil marketsJuly 2025 Update & High Yield Stock Recommendations - newser.com
Why Bio Rad Laboratories Inc. (BUWA) stock is a must watch ticker2025 Price Action Summary & Weekly High Return Forecasts - newser.com
Is Bio Rad Laboratories Inc. Class B stock expanding market penetration2025 Valuation Update & Accurate Entry and Exit Point Alerts - newser.com
How Bio Rad Laboratories Inc. (BUWA) stock stacks up against competitorsPortfolio Return Report & Fast Momentum Stock Entry Tips - newser.com
Is Bio Rad Laboratories Inc. Class stock at risk of policy regulationForecast Cut & Consistent Profit Trading Strategies - newser.com
Why Bio Rad Laboratories Inc. Class stock stays on top picksJuly 2025 Analyst Calls & Precise Buy Zone Tips - newser.com
Is Bio Rad Laboratories Inc. (BUW) stock cheap vs fundamentals2025 Institutional Moves & Accurate Trade Setup Notifications - newser.com
Is Bio Rad Laboratories Inc. (BUW) stock a buy before new product rolloutMarket Performance Summary & Low Risk Investment Opportunities - newser.com
Published on: 2025-11-21 01:52:15 - newser.com
Bacterial Cell Culture Market Size, Outlook 2032 by Key - openPR.com
Will Bio Rad Laboratories Inc. Class stock rise with strong economyPortfolio Performance Report & Daily Profit Focused Stock Screening - newser.com
What is the fair value estimate for Bio Rad Laboratories Inc. Class B stock in 2025Buy Signal & Real-Time Volume Surge Alerts - newser.com
What RSI levels show for Bio Rad Laboratories Inc. Class B stockJuly 2025 Intraday Action & AI Enhanced Execution Alerts - newser.com
What valuation ratios show for Bio Rad Laboratories Inc. (BUWA) stockMarket Movers & Growth Focused Stock Pick Reports - newser.com
Can Bio Rad Laboratories Inc. (BUWA) stock ride next bull market cycle2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
How Bio Rad Laboratories Inc. (BUWA) stock performs in volatility spikesWeekly Stock Report & Momentum Based Trading Ideas - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock positioned for secular growthMarket Growth Summary & Free High Accuracy Swing Entry Alerts - newser.com
How Bio Rad Laboratories Inc. Class B stock trades pre earnings2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
Published on: 2025-11-19 23:54:32 - newser.com
Published on: 2025-11-19 22:26:31 - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock deliver compounding returnsDollar Strength & AI Enhanced Trading Alerts - newser.com
Bio Rad Laboratories Inc. stock trend forecastM&A Rumor & AI Enhanced Market Trend Forecasts - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock see valuation expansion2025 Earnings Impact & Precise Swing Trade Alerts - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock a buy during volatile markets2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
Is Bio Rad Laboratories Inc. (BUW) stock a good hedge against inflation2025 Winners & Losers & High Accuracy Trade Alerts - newser.com
Exit strategy if you’re trapped in Bio Rad Laboratories Inc.2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):